Matthew S. Gentry

University of Florida

NIH Rank #3390
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.6M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#3,390
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.6M across 5 grants · National rank #3390.

Top grants by award amount

Matthew S. Gentry's NIH grant portfolio, ranked by award amount.

  • 5R35NS116824-05R35
    Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential
    $1M
    award amount
  • 1R01CA288696-01R01
    Targeting Glycogen Metabolism in Ewing's Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications
    $600.7K
    award amount
  • 5R01CA266004-04R01
    Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis
    $504.8K
    award amount
  • 5R33NS111081-03R33
    Treatment of Lafora disease with an antibody-enzyme fusion
    $369.8K
    award amount
  • 3R35NS116824-05S1R35
    Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential
    $74.3K
    award amount

Affiliation

Institutions that have administered grants for Matthew S. Gentry.

Affiliated with University of Florida (FL).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Florida
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3390
  6. 2024
    Entered Top 25% Nationally
    Ranked #3390